Trial Profile
Real-world Data on Dapagliflozin: Characteristics and Health Outcomes of Patients With Type 2 Diabetes Treated With Dapagliflozin in Conjunction With Insulin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Insulin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 13 Jun 2017 Results (n=136) presented at the 77th Annual Scientific Sessions of the American Diabetes Association
- 06 Mar 2017 Status changed from not yet recruiting to completed.
- 26 Sep 2016 New trial record